Načítá se...
Raised serum cystatin C can be a potential biomarker of frailty detected by cumulative deficit model
OBJECTIVE: Identification of frailty by clinical criteria is often delayed to the advanced stage. A reliable biomarker to identify frailty or its risk does not currently exist. We aimed to determine the association between serum cystatin C and frailty in subjects without renal dysfunction. METHODS:...
Uloženo v:
| Vydáno v: | Aging Med (Milton) |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6880677/ https://ncbi.nlm.nih.gov/pubmed/31942492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/agm2.12038 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|